Heart Health on Cycle: Blood Pressure and CV Risk
Blood Work · 6 min read · Updated on May 23, 2026
The cardiovascular impact is the most serious long-term effect of a cycling career — much more than gynecomastia or acne. It combines elevated blood pressure, a degraded lipid profile, thicker blood (high hematocrit), and in some users left ventricular hypertrophy from the heart's extra workload [1]. All of this is silent at the start [5].
This guide focuses on cardiovascular-specific monitoring: blood pressure (home measurement and thresholds), cardiovascular blood markers, warning signs to recognize, and the most cardiotoxic compounds. It belongs to the blood work on cycle cluster and complements cholesterol and hematocrit.
The cardiovascular mechanics of a cycle
Several effects converge on cycle to put load on the cardiovascular system.
- Sodium and water retention. Testosterone, and especially aromatizing compounds, raise extracellular volume — the first driver of blood pressure rise.
- Vasoconstriction and endothelial impact. Some compounds (trenbolone notably) impair vascular endothelial function, which raises blood pressure and favors atherosclerosis.
- High hematocrit. Thicker blood demands more work from the heart and raises pressure. See the hematocrit and steroids guide.
- Dyslipidemia. HDL crash, LDL rise, especially under orals — the substrate of long-term coronary atheroma.
- Left ventricular hypertrophy (LVH). Documented in long-term users, especially with cardiotoxic compounds and cumulative cycles over years. The heart thickens in response to the increased afterload.
Blood pressure: thresholds and home measurement
Reference thresholds
| Pressure | Optimal | Elevated | Hypertension |
|---|---|---|---|
| Systolic (SBP) | < 120 mmHg | 120–129 mmHg | ≥ 130 mmHg (Stage 1) / ≥ 140 mmHg (Stage 2) |
| Diastolic (DBP) | < 80 mmHg | < 80 mmHg | ≥ 80 mmHg (Stage 1) / ≥ 90 mmHg (Stage 2) |
Note: AHA/ACC 2017 guidelines lowered the US hypertension threshold to 130/80 mmHg (Stage 1). On cycle, a few mmHg rise is common and often benign [2]. The problem is sustained elevation at 130/80 mmHg and beyond, which should drive an adjustment (dose, AI if estrogenic retention, blood donation if high hematocrit). Past 160/100 mmHg, a medical consult is warranted.
Home measurement: the only reliable read
Blood pressure taken once a year at the doctor's office has no follow-up value on cycle. The useful method:
- Arm cuff (not wrist — less reliable). Validated models, low cost (Omron and Withings are widely cited).
- Always under the same conditions: seated, back supported, arm at heart level, after 5 min of rest.
- Three consecutive measurements 1 minute apart, take the average of the last two.
- Same times of day: ideally morning (fasted, before coffee) and evening, 2 to 3 times a week through the cycle.
- Not right after exercise, coffee, or nicotine. Otherwise the reading is artificially high.
The most cardiotoxic compounds
- Trenbolone. The compound with the worst cardiovascular footprint — endothelial impact, blood pressure rise, heavy lipid impact, significant cardiac demand [3]. See the trenbolone acetate page.
- High-dose stacked 17α-alkylated orals. Combined lipid and blood pressure impact; especially Anadrol and Dianabol which raise retention.
- Very high-dose testosterone. The dose-response between androgens and cardiovascular impact is broadly linear — a cycle at 250 mg/wk does not have the same impact as 1000 mg/wk.
- Erythropoietic compounds (boldenone). Marked hematocrit rise increases cardiac afterload.
- Associated stimulants. Clenbuterol, ephedrine, high-dose caffeine add their own cardiovascular load — pairing them with steroids in a cutting cycle multiplies blood pressure risk.
Cardiovascular blood markers
Beyond the standard lipid panel, several markers refine cardiovascular risk evaluation on prolonged cycling [1].
| Marker | Target | Use on cycle |
|---|---|---|
| Apolipoprotein B (apoB) | < 90 mg/dL | Atherogenic particle count — more precise than LDL |
| Lp(a) | < 30 mg/dL | Genetic CV risk — one-time measurement enough |
| hs-CRP | < 2 mg/L | Low-grade systemic inflammation |
| Homocysteine | < 12 µmol/L | Vascular risk marker — useful with family history |
| Home BP | < 130/80 mmHg average | Ongoing tracking (see dedicated section) |
Imaging for long cycles / career users
- Echocardiogram (TTE). Measures left ventricular thickness and systolic function. Indication: users on cumulative cycles for years, or at the first symptomatic alert.
- Coronary calcium score. Low-dose CT that measures calcified atheroma in the coronaries. Direct, tangible image of long-term atherosclerotic risk — worth discussing with a cardiologist from the forties onward, or earlier if the lipid profile is heavily degraded.
- Resting ECG. Simple exam to request at baseline and at the first symptom.
Warning signs to recognize
Certain signs demand an immediate stop of the cycle and a prompt consult. Do not rationalize them.
- Chest pain (pressure, burning, heaviness), especially on exertion or recovery.
- Disproportionate shortness of breath on exertion, or new shortness of breath at rest.
- Frequent palpitations or a persistent feeling of irregular heartbeat.
- Morning headaches sustained over several days — possible sign of installed hypertension.
- Blurred vision, dizziness, faintness.
- Lower-limb edema (ankles, legs) that does not resolve.
Reducing the cardiovascular load of a cycle
- Regular cardio. Moderate endurance activity (zone 2 for 150 to 200 min per week), plus a few harder sessions. Improves HDL, endothelial health, blood pressure, and the heart's capacity to handle afterload.
- Moderate compounds and doses. Prefer a contained-dose testosterone base to a 1500 mg/wk multi-compound blast. Avoid trenbolone + orals + stimulants stacks.
- Active monitoring. Home BP + regular bloods. Without measurement, no adjustment is possible.
- Lifestyle. Enough sleep, stress management, no smoking, alcohol very limited — all amplify cardiovascular risk on top of a cycle.
- No blast and cruise without cardiology follow-up. Blast and cruise amounts to permanent androgen exposure — the cumulative cardiovascular drift justifies background cardiology monitoring.
Frequently asked questions
My blood pressure is at 135/85 mmHg on cycle: should I worry?
Under the current AHA/ACC thresholds, 135/85 mmHg falls into Stage 1 hypertension — not yet severe, but a signal to take seriously in a cycle context. The reasonable call: verify the trend over several days under good measurement conditions (morning and evening, after 5 min of rest), cut dietary sodium, optimize sleep, ramp up cardio. If the elevation persists despite these adjustments, or if it crosses 140/90 mmHg repeatedly, reconsider the dose and/or an AI if estradiol is elevated. Past 160/100 mmHg, medical consult.
Is left ventricular hypertrophy reversible after stopping?
A portion of steroid-induced LVH is reversible after stopping, over several months. Another portion — particularly the myocardial fibrosis associated with long, cumulative cycles using cardiotoxic compounds — is only partially reversible. That is one of the reasons the decision to continue a multi-year cycling career deserves cardiology follow-up (echocardiogram every 1 to 2 years typically for long-term users).
Is clenbuterol paired with a cycle really dangerous for the heart?
Clenbuterol is a beta-2 agonist that raises heart rate, blood pressure, and in some users has been associated with cardiac hypertrophy and arrhythmias. Paired with a cycle that already raises BP and hematocrit, its cardiovascular impact stacks. The practice of using it for cutting finishes, sometimes alongside trenbolone, is one of the highest-risk combinations reported. Cautious duration limits (a few weeks max, with off phases) and dose caps do not eliminate the risk, they limit it.
Sources
Studies and scientific publications this guide relies on.
- Baggish AL, Weiner RB, Kanayama G, et al. (2017). Cardiovascular Toxicity of Illicit Anabolic-Androgenic Steroid Use. Circulation. doi: 10.1161/CIRCULATIONAHA.116.026945
Étude transversale (86 utilisateurs AAS au long cours vs 54 non-utilisateurs) : dysfonction systolique du ventricule gauche, dysfonction diastolique, athérosclérose coronaire accélérée et volume coronaire calcifié augmenté chez les utilisateurs chroniques.
- Smit DL, Grefhorst A, Buijs MM, et al. (2022). Prospective study on blood pressure, lipid metabolism and erythrocytosis during and after androgen abuse. Andrologia. doi: 10.1111/and.14372
Étude prospective HAARLEM : élévation de la pression artérielle pendant le cycle (gain ~8 mmHg de systolique en moyenne), réversibilité partielle à 12 mois, avec une variabilité individuelle importante et une prédominance chez les sujets utilisant des composés aromatisants à dose élevée.
- Krieg A, Scharhag J, Albers T, et al. (2007). Cardiac tissue Doppler in steroid users. International Journal of Sports Medicine. doi: 10.1055/s-2007-964848
Étude par Doppler tissulaire chez des bodybuilders : dysfonction diastolique significative chez les utilisateurs d'AAS comparée aux athlètes de force non utilisateurs et aux témoins, malgré une fonction systolique conservée.
- Lincoff AM, Bhasin S, Flevaris P, et al. (2023). Cardiovascular Safety of Testosterone-Replacement Therapy. New England Journal of Medicine. doi: 10.1056/NEJMoa2215025
RCT TRAVERSE : 5 246 hommes hypogonadiques à risque cardiovasculaire élevé, suivi médian 33 mois ; la TRT n'augmente pas l'incidence d'événements cardiovasculaires majeurs vs placebo, mais augmente la fibrillation auriculaire et les épisodes de thromboembolie veineuse (incidences faibles mais statistiquement significatives).
- Pope HG Jr, Wood RI, Rogol A, et al. (2014). Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. Endocrine Reviews. doi: 10.1210/er.2013-1058
Énoncé scientifique : l'usage de stéroïdes à doses supraphysiologiques est associé à une élévation soutenue de la pression artérielle, une dégradation du profil lipidique et une hypertrophie ventriculaire gauche cumulative chez les utilisateurs chroniques.
Guides liés
Track your cycle with real data
Daily journal, 52 compounds, blood work and AI analysis — to apply what you just read and track results cycle after cycle.
Free 5-day trial — no credit card